To Learn the Evaluation Process of Potential Lung Transplant Candidates
Evaluation of Potential Lung Transplant Candidates
Types of advanced lung diseases for which transplantation is an option
Indications for bilateral vs. single vs. heart-lung transplant
Indications for transplantation
Contraindications to transplantation
Evaluation of the Potential Lung Donor and Observation of Organ Recovery at a Donor Hospital
Observation of Lung Transplant Surgery
Bronchoscopy of Lung Transplant Recipients and Management of Post Transplant Airway Complications
In-House Management of Lung Transplant Recipients in the Peri-Operative Period
Ventilator management of lung recipients
ECMO management
Hemodynamic management of lung recipients
Infectious disease prophylaxis
Diagnosis and management of acute allograft rejection
Immunosuppression
Outpatient Management of Lung Transplant Recipients
Outpatient monitoring of the lung allograft, inlcluding evaluation for acute cellular and antibody-mediated rejection
Diagnosis and management of acute allograft rejection including histopathological evaluation and grading
PFT interpretation in lung recipients
Outpatient immunosuppression management
Recognition and management of long-term complications including chronic rejection
To Gain Enough Experience in Above to Earn UNOS Certification
Primary and follow up care of at least 15 newly transplanted lung recipients (documented in a log with the date of transplant and patient’s UNOS number/EPIC MRN; the log must be signed off by the director of the training program)
Participate in the evaluation, the donation process and management of 3 multiple organ donors (who are donating a lung or heart/lung) (documented in a log)
Observe at least 3 lung or heart/lung procurements (documented in a log with a date that includes the date of procurement, location of the donor and UNOS donor ID)
Observe at least 3 lung transplants
Management of Patients with Pulmonary Hypertension
Assessment and work-up of patients with pulmonary hypertension
Indications for the various available therapies and appropriate indications and use of the available oral therapies
Initiation and ongoing management of patients with continuous intravenous epoprostenol, treprostinil, SQ treprostinil and inhaled therapies
Observe/participate in performance of RHCs (maintain precedures in a log)
Experience in reading PH ECHOs
Participation in the monthly PH conference
Diagnosis and Management of Patients with Interstitial Lung Disease
Participation in the multidisciplinary pathology conference
Assessment and work up of various ILD diseases
Initiation and ongoing management of patients on immunosuppresive and anti-fibrotic therapy
Diagnosis and Management of Patients with Cystic Fibrosis and Non-CF Bronchiectasis
Indication for genetic therapy
Treatment of chronic disease (both pulmonary and extra-pulmonary manifestations)
Management of acute exacerbation in the inpatient and outpatient setting
